Drugs / ALS-008112
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02231671 | Aug → Sep 2014 | respiratory syncytial virus infectious disease | Alios Biopharma Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALS-008112 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02231671 ↗ |
| Route | Intravenous | “IV (intravenous) microtracer dose of ALS-008112 is administered” NCT02231671 ↗ |